» Articles » PMID: 33076503

Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR

Overview
Journal Cells
Publisher MDPI
Date 2020 Oct 20
PMID 33076503
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

During the last two decades, the constitutive androstane receptor (CAR; NR1I3) has emerged as a master activator of drug- and xenobiotic-metabolizing enzymes and transporters that govern the clearance of both exogenous and endogenous small molecules. Recent studies indicate that CAR participates, together with other nuclear receptors (NRs) and transcription factors, in regulation of hepatic glucose and lipid metabolism, hepatocyte communication, proliferation and toxicity, and liver tumor development in rodents. Endocrine-disrupting chemicals (EDCs) constitute a wide range of persistent organic compounds that have been associated with aberrations of hormone-dependent physiological processes. Their adverse health effects include metabolic alterations such as diabetes, obesity, and fatty liver disease in animal models and humans exposed to EDCs. As numerous xenobiotics can activate CAR, its role in EDC-elicited adverse metabolic effects has gained much interest. Here, we review the key features and mechanisms of CAR as a xenobiotic-sensing receptor, species differences and selectivity of CAR ligands, contribution of CAR to regulation hepatic metabolism, and evidence for CAR-dependent EDC action therein.

Citing Articles

Constitutive Androstane Receptor Regulates Germ Cell Homeostasis, Sperm Quality, and Male Fertility via Akt-Foxo1 Pathway.

Monrose M, Holota H, Martinez G, Damon-Soubeyrand C, Thirouard L, Martinot E Adv Sci (Weinh). 2024; 11(43):e2402082.

PMID: 39318179 PMC: 11578384. DOI: 10.1002/advs.202402082.


Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression.

Sonkar R, Ma H, Waxman D Toxicol Sci. 2024; 200(2):324-345.

PMID: 38710495 PMC: 11285164. DOI: 10.1093/toxsci/kfae057.


5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in Lung Cancer.

Shao J, Xu Y, Olsen R, Kasparian S, Sun K, Mathur S Cells. 2024; 13(8.

PMID: 38667328 PMC: 11049556. DOI: 10.3390/cells13080715.


Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An study.

Solan M, Lavado R Curr Res Toxicol. 2023; 5:100116.

PMID: 37575337 PMC: 10412865. DOI: 10.1016/j.crtox.2023.100116.


Polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans, pesticides, and diabetes in the Anniston Community Health Survey follow-up (ACHS II): single exposure and mixture analysis approaches.

Pavuk M, Rosenbaum P, Lewin M, Serio T, Rago P, Cave M Sci Total Environ. 2023; 877:162920.

PMID: 36934946 PMC: 11801232. DOI: 10.1016/j.scitotenv.2023.162920.


References
1.
Chai S, Lin W, Li Y, Chen T . Drug discovery technologies to identify and characterize modulators of the pregnane X receptor and the constitutive androstane receptor. Drug Discov Today. 2019; 24(3):906-915. PMC: 6421094. DOI: 10.1016/j.drudis.2019.01.021. View

2.
Kojima H, Takeuchi S, Sanoh S, Okuda K, Kitamura S, Uramaru N . Profiling of bisphenol A and eight its analogues on transcriptional activity via human nuclear receptors. Toxicology. 2018; 413:48-55. DOI: 10.1016/j.tox.2018.12.001. View

3.
Finkelstein D, Lamba V, Assem M, Rengelshausen J, Yasuda K, Strom S . ADME transcriptome in Hispanic versus White donor livers: evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics. Xenobiotica. 2006; 36(10-11):989-1012. DOI: 10.1080/00498250600861769. View

4.
Kobayashi K, Hashimoto M, Honkakoski P, Negishi M . Regulation of gene expression by CAR: an update. Arch Toxicol. 2015; 89(7):1045-55. DOI: 10.1007/s00204-015-1522-9. View

5.
Coperchini F, Awwad O, Rotondi M, Santini F, Imbriani M, Chiovato L . Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA). J Endocrinol Invest. 2016; 40(2):105-121. DOI: 10.1007/s40618-016-0572-z. View